CD2AP and Alzheimer disease: Recent work has further demonstrated that CD2AP, similar to MYO1F, is upregulated in microglia during AD, highlighting the possibility that the MYO1F–CD2AP interaction underlies cytoskeletal remodelling and cargo trafficking in reactive microglia, contributing to the cellular reprogramming observed in neurodegenerative diseases.